The Body's Own Cannabis-Like Chemical Controls How We Switch Between Freeze and Flight | Research

The takeaway

The endocannabinoid 2-AG plays a critical role in determining whether animals freeze or flee in response to threats, regulating the transition between passive and active defense.

Fear neuroscientists, PTSD researchers, endocannabinoid pharmacologists, anxiety disorder specialists

What the researchers found

Inhibiting 2-AG synthesis enhanced freezing to early cues and promoted active responses during high threat imminence in learned fear. In innate fear (looming shadow), 2-AG depletion biased behavior toward freezing and increased time in safe zones. 2-AG signaling promotes active defensive responses and regulates the scaling of passive-to-active behavioral transitions.

Why it matters

Maladaptive fear responses — freezing when you should flee, or panicking when you should stay calm — are hallmarks of anxiety disorders and PTSD. Understanding that 2-AG controls these transitions could lead to treatments that restore appropriate threat responses.

The numbers in context

Two fear paradigms tested: serial compound stimulus (learned) and looming shadow (innate). 2-AG inhibition shifted behavior toward passive freezing in both paradigms. Active defensive responses were promoted by intact 2-AG signaling.

How the study worked

Pharmacological manipulation of 2-AG signaling in mice tested in two paradigms: serial compound stimulus (learned fear) and looming shadow (innate fear). Behavioral state transitions between freezing (passive) and darting/fleeing (active) defense were analyzed.

What this study cannot tell us

Mouse behavioral paradigms may not fully translate to human threat responses. Pharmacological 2-AG manipulation is systemic, not region-specific. Acute drug effects may differ from chronic endocannabinoid changes. Did not test cannabinoid receptor agonists directly.

How to read the evidence

Well-controlled pharmacological study across two complementary fear paradigms, limited by mouse model and systemic drug delivery.

When this study was published

Published 2026, advancing understanding of endocannabinoid defense regulation.

The bigger picture

The endocannabinoid system doesn't just dampen fear — it helps calibrate the appropriate response to different threat levels. This nuanced role explains why cannabis and related compounds have such complex effects on anxiety: they're tuning a behavioral switch, not just turning fear off.

Questions still open

Could 2-AG-based therapies help people with PTSD who have 'frozen' threat responses? Does cannabis use shift people's default defensive style? How do 2-AG levels change in anxiety disorders?

Common questions

How does the endocannabinoid system affect fear responses?

The body's own cannabis-like chemical 2-AG helps determine whether you freeze or take action in response to threats. When 2-AG signaling is disrupted, animals become 'stuck' in passive freezing rather than switching to active escape.

What does this mean for anxiety and PTSD?

People with anxiety disorders and PTSD often have inappropriate fear responses — either freezing when action is needed or remaining hypervigilant. The finding that 2-AG controls this behavioral switch suggests endocannabinoid-based treatments could help restore adaptive threat responses.

Read the original research

Endocannabinoid modulation of defensive state transitions to innate and learned threat.

Psychopharmacology, 243(2), 325-338

View on PubMed ↗Publisher’s paper ↗

Citation

Loomba, Niharika; Cao, Anyu; Charles, Senna; Kandil, Isaac; Kwon, Michelle; Patel, Sachin. (2026). Endocannabinoid modulation of defensive state transitions to innate and learned threat.. Psychopharmacology, 243(2), 325-338. https://doi.org/10.1007/s00213-025-06812-z